Trial · NCT04114539
Results by group87
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 87
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs) and Their Relationship (Unrelated, Possibly Related, or Probably Related) | Ecopipam HCI 2 mg/kg/Day | Participants with any AEs | 84 | Participants | |
| Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs) and Their Relationship (Unrelated, Possibly Related, or Probably Related) | Ecopipam HCI 2 mg/kg/Day | Participants with SAEs | 2 | Participants | |
| Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs) and Their Relationship (Unrelated, Possibly Related, or Probably Related) | Ecopipam HCI 2 mg/kg/Day | Participants with unrelated AEs | 44 | Participants | |
| Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs) and Their Relationship (Unrelated, Possibly Related, or Probably Related) | Ecopipam HCI 2 mg/kg/Day | Participants with possibly related AEs | 27 | Participants | |
| Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs) and Their Relationship (Unrelated, Possibly Related, or Probably Related) | Ecopipam HCI 2 mg/kg/Day | Participants with probably related AEs | 13 | Participants | |
| Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs) and Their Relationship (Unrelated, Possibly Related, or Probably Related) | Ecopipam HCI 2 mg/kg/Day | Participants with unrelated SAEs | 1 | Participants | |
| Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs) and Their Relationship (Unrelated, Possibly Related, or Probably Related) | Ecopipam HCI 2 mg/kg/Day | Participants with possibly related SAEs | 1 | Participants | |
| Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs) and Their Relationship (Unrelated, Possibly Related, or Probably Related) | Ecopipam HCI 2 mg/kg/Day | Participants with probably related SAEs | 0 | Participants | |
| Change From Baseline in Hematology Parameters: Basophils to Leukocytes Ratio Reported in Percentage of Cells | Ecopipam HCI 2 mg/kg/Day | -0.1 | Standard Deviation 0.91 | percentage of cells | |
| Change From Baseline in Hematology Parameters: Eosinophils to Leukocytes Ratio Reported in Percentage of Cells | Ecopipam HCI 2 mg/kg/Day | 0.1 | Standard Deviation 1.52 | percentage of cells | |
| Change From Baseline in Hematology Parameters: Erythrocytes | Ecopipam HCI 2 mg/kg/Day | 0.04 | Standard Deviation 0.263 | 10^12 cells per liter | |
| Change From Baseline in Hematology Parameters: Hematocrit | Ecopipam HCI 2 mg/kg/Day | 0.01 | Standard Deviation 0.029 | liter of cells per liter of blood (L/L) | |
| Change From Baseline in Hematology Parameters: Hemoglobin | Ecopipam HCI 2 mg/kg/Day | 0.08 | Standard Deviation 0.429 | millimoles per liter (mmoL/L) | |
| Change From Baseline in Hematology Parameters: Leukocytes and Platelets | Ecopipam HCI 2 mg/kg/Day | Leukocytes | 0.15 | Standard Deviation 1.349 | 10^9 cells per liter |
| Change From Baseline in Hematology Parameters: Leukocytes and Platelets | Ecopipam HCI 2 mg/kg/Day | Platelets | 4.1 | Standard Deviation 51.49 | 10^9 cells per liter |
| Change From Baseline in Hematology Parameters: Lymphocytes to Leukocytes Ratio Reported in Percentage of Cells | Ecopipam HCI 2 mg/kg/Day | 0.2 | Standard Deviation 10.20 | percentage of cells | |
| Change From Baseline in Hematology Parameters: Monocytes to Leukocytes Ratio Reported in Percentage of Cells | Ecopipam HCI 2 mg/kg/Day | 0.2 | Standard Deviation 1.43 | percentage of cells | |
| Change From Baseline in Hematology Parameters: Neutrophils to Leukocytes Ratio Reported in Percentage of Cells | Ecopipam HCI 2 mg/kg/Day | -0.3 | Standard Deviation 10.45 | percentage of cells | |
| Change From Baseline in Serum Chemistry Parameters: Alanine Aminotransferase, Alkaline Phosphatase, Aspartate Aminotransferase, Lactase Dehydrogenase | Ecopipam HCI 2 mg/kg/Day | Alanine Aminotransferase | 2.3 | Standard Deviation 9.41 | units per liter (U/L) |
| Change From Baseline in Serum Chemistry Parameters: Alanine Aminotransferase, Alkaline Phosphatase, Aspartate Aminotransferase, Lactase Dehydrogenase | Ecopipam HCI 2 mg/kg/Day | Alkaline Phosphatase | -4.7 | Standard Deviation 80.71 | units per liter (U/L) |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04114539/results